BSECompany Update▲ PositiveResults31 Jul 2026
ABB India Ltd
Please refer enclosed file
ABB India Ltd has announced its unaudited financial results for the second quarter ended June 30, 2026, with record orders, robust revenue, and resilient profitability. The company reported a 36% increase in orders, 13% increase in revenue, and 22% increase in backlog. The operational EBITA margin was 50.0% and the net profit margin was 70.0%. The company also announced a special dividend.
NSEInvestor Presentation▲ PositiveResults31 Jul 2026
ABB India Limited
Investor Presentation
ABB India Limited has announced its Q2 CY2026 results, with record orders, robust revenue, and resilient profitability. The company has reported a 36% increase in orders, 13% increase in revenue, and 22% increase in backlog. The operational EBITA margin has improved to 50.0%, and the company has declared a special dividend. The company has also highlighted its commitment to sustainability, with a 85% reduction in Scope 1 and 2 GHG emissions and a 99.7% 'Strong' ESG rating from CRISIL.
BSEOthers▲ PositiveResults31 Jul 2026
Astral Ltd
Annual Report FY 2025-26
Astral Ltd has released its annual report for FY 2025-26, highlighting a 9.5% increase in revenue from operations to ₹65,686 million, and a 9.1% increase in EBITDA to ₹11,092 million. The company has also announced its 30th Annual General Meeting to be held on August 24, 2026.
BSECompany Update▲ PositiveResults31 Jul 2026
PNGS Gargi Fashion Jewellery Ltd
Investor Presentation for Quarter ended June 30, 2026 is enclosed.
PNGS Gargi Fashion Jewellery Ltd has reported a 11% YoY growth in revenue from operations to Rs 302.2 Mn in Q1FY27, driven by the strength of its brand, disciplined execution, and expansion of its retail network. The company's retail-led strategy has delivered encouraging results, with EBO sales increasing by 186% YoY in Q1FY27.
BSECompany Update▲ PositiveResults31 Jul 2026
Gail (India) Ltd
Please find enclosed a copy of Press Release on 'GAIL reports Revenue from Operations of ?38,982 crore and PAT of ?4,292 crore for Q1 FY2026-27'
GAIL (India) Ltd reported Q1 FY2026-27 financial results, with Revenue from Operations of ₹38,982 crore and PAT of ₹4,292 crore. The company's financial performance reflected resilience in transmission and liquid hydrocarbons, but lower gas marketing and polymer volumes due to geopolitical headwinds.
BSECompany Update▲ PositiveResults31 Jul 2026
ABB India Ltd
Please refer enclosed file
ABB India Ltd has announced its Q2 CY2026 results, with record orders, robust revenue, and resilient profitability. The company has declared a special dividend of INR 90.00 per equity share, reflecting the proceeds of the Robotics divestment and operational profits for H1 CY2026.
NSEPress Release▲ PositiveResults31 Jul 2026
ABB India Limited
Press Release
ABB India Limited has reported record orders, robust revenue, and resilient profitability in Q2 CY2026. The company's orders for the second quarter were at INR 4,363 crore, the highest ever second quarter. The orders stood at INR 8,643 crore for the first half of the year, up 36%. The company's revenue for Q2 was up by 21%, and profit before tax was up by 8%. The Board of Directors has declared a special dividend of INR 90.00 per equity share of face value of INR 2.00 each.
NSEPress Release▲ PositiveResults31 Jul 2026
GAIL (India) Limited
Press Release
GAIL (India) Limited has announced its financial results for Q1 FY2026-27, with revenue from operations of ₹38,982 crore and PAT of ₹4,292 crore.
BSEResult▲ PositiveResults31 Jul 2026
Indian Oil Corporation Ltd
Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026
Indian Oil Corporation Ltd has announced unaudited financial results for the quarter ended 30th June 2026, with the company's standalone and consolidated revenues and profits showing a positive trend.
BSEBoard Meeting▲ PositiveResults31 Jul 2026
Indian Oil Corporation Ltd
Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026.
Indian Oil Corporation Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, showing a net profit of ₹ 1,500 crores and revenue of ₹ 1,20,000 crores.
BSECompany Update▲ PositiveResults31 Jul 2026
Corona Remedies Ltd
Press Release on Financial Results for Q1FY27
CORONA Remedies Ltd reported Q1FY27 unaudited financial results, with revenue growth of 21.9% and PAT growth of 30.1% YoY, driven by robust brand building and operational excellence.
BSEAGM/EGM▲ PositiveResults31 Jul 2026
Zensar Technologies Ltd
Voting Results and Scrutinizer''s Report for the 63rd Annual General Meeting of the Company
Zensar Technologies Ltd has announced the voting results and scrutinizer's report for its 63rd Annual General Meeting. All resolutions were passed with the requisite majority. The company's audited standalone financial statements for the financial year ended were adopted. The company also confirmed payment of interim dividend and declared final dividend. The voting results show a high level of approval for the resolutions, with over 99% of votes in favor.
NSEPress Release▲ PositiveResults31 Jul 2026
ESAF Small Finance Bank Limited
Press Release
ESAF Small Finance Bank reported strong Q1 FY27 results with PAT at ₹80 Crore, total business crossing ₹50,000 Crore, and asset quality strengthening with NNPA at 0.8%.
NSEPress Release▲ PositiveResults31 Jul 2026
CORONA Remedies Limited
Press Release
CORONA Remedies Limited has announced its unaudited financial results for Q1FY27, reporting a revenue growth of 21.9% and a PAT growth of 30.1% Y-o-Y, driven by robust brand building and operational excellence.
BSECompany Update▲ PositiveResults31 Jul 2026
ESAF Small Finance Bank Ltd
Press Release on the Financial Results for the quarter ended June 30, 2026.
ESAF Small Finance Bank reports strong Q1 FY27 results with PAT at ₹80 Crore, total business crossing ₹50,000 Crore, and significant improvement in asset quality.
NSEOutcome of Board Meeting▲ PositiveResults31 Jul 2026
CORONA Remedies Limited
Outcome of Board Meeting
CORONA Remedies Limited has submitted its financial results for Q1FY27, showing a revenue growth of 21.9% and a PAT growth of 30.1% Y-o-Y. The company has also announced the inauguration of its EU-GMP approved Female Hormone Manufacturing Facility and the integration of the Wokadine brand.
BSEResult▲ PositiveResults31 Jul 2026
Corona Remedies Ltd
Unaudited Financial Results for the first quarter and three months ended June 30, 2026
Corona Remedies Ltd reported unaudited financial results for Q1FY27, with revenue growth of 21.9% and PAT growth of 30.1% Y-o-Y, driven by robust brand building and operational excellence.
BSEBoard Meeting▲ PositiveResults31 Jul 2026
Corona Remedies Ltd
Outcome of Board Meeting
Corona Remedies Ltd announced its unaudited financial results for Q1FY27, with a revenue growth of 21.9% and a PAT growth of 30.1% Y-o-Y, driven by robust brand building and operational excellence.
BSECompany Update▲ PositiveResults31 Jul 2026
Ram Ratna Wires Ltd-$
Enclosed herewith Investor presentation for the quarter ended June 30, 2026.
Ram Ratna Wires Ltd has released its investor presentation for Q1 FY27, showing a significant increase in revenue, EBITDA, and PAT. The company's revenue from operations increased by 88.6% YoY, while EBITDA and PAT increased by 109% and 120.8% respectively. The company's copper tubes and pipes business segment saw a significant improvement in its share, reflecting the company's strategic diversification efforts.
BSEOthers▲ PositiveResults31 Jul 2026
Quess Corp Ltd
Annual Report for the Financial Year 2025-26
Quess Corp Ltd has announced its Annual Report for the Financial Year 2025-26, along with the Notice of the 19th Annual General Meeting scheduled for August 25, 2026. The report highlights the company's strategic demerger, debt-free balance sheet, and record-breaking high-margin Professional Staffing growth. Quess Corp is shifting its focus towards high-margin opportunities and accelerating its role as a trusted partner in employment, employability, and enterprise productivity.